Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay

Information

  • Research Project
  • 9625757
  • ApplicationId
    9625757
  • Core Project Number
    R43AI136197
  • Full Project Number
    5R43AI136197-02
  • Serial Number
    136197
  • FOA Number
    PA-16-302
  • Sub Project Id
  • Project Start Date
    1/16/2018 - 6 years ago
  • Project End Date
    12/31/2019 - 4 years ago
  • Program Officer Name
    CHALLBERG, MARK D
  • Budget Start Date
    1/1/2019 - 5 years ago
  • Budget End Date
    12/31/2019 - 4 years ago
  • Fiscal Year
    2019
  • Support Year
    02
  • Suffix
  • Award Notice Date
    12/19/2018 - 6 years ago

Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay

Discovery  of  Yellow  Fever Virus-­Specific  Epitopes  for  Development  of  an  Accurate  Serodiagnostic Assay    Abstract    Antibodies to many pathogenic viruses can be detected in blood, serum and/or saliva. Among these  are many arboviruses, that share endemic regions in the western hemisphere and in other parts of the  world. These include the related flaviviruses yellow fever virus (YFV), dengue virus (DENV), Zika virus  (ZIKV) and West Nile virus (WNV) as well as the alphavirus chikungunya virus (CHIKV). Antibodies to  these viruses are often cross-­reactive, making diagnostics for a particular virus challenging. The current  outbreak  of  yellow  fever  in  Brazil  and  the  high  mortality  associated  with  this  disease  as  well  as  the  recent  history  of  outbreaks  in  South  America  and  Africa  create  an  urgent  need  for  YFV-­specific  serodiagnostics, to aid control of the spread of yellow fever. Moreover, such diagnostics would facilitate  clinical  and  public  health  efforts  against  these  and  other,  related  arboviruses.  We  propose  a  novel  strategy to develop methods for specific and sensitive detection of antibodies against YFV that do not  cross react with other arboviruses. We will employ an innovative, comprehensive proteomic approach  with a unique serum sample collection that will allow discovery and validation of specific biomarkers  capable  of  distinguishing  YFV  from  other  arboviruses.  This  will  allow  us  to  develop  a  specific  and  sensitive test for YFV infection in Phase II of this project. A practical, sensitive and specific test for YFV  infection  is  a  high  priority  goal  due  to  the  recent  outbreak  of  yellow  fever  in  Brazil,  possible  future  outbreaks and the likely spread of yellow fever to southern US states bordering the Gulf of Mexico and  Puerto Rico where Aedes spp. mosquitos might rapidly spread the infection.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    295679
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:295679\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    IMMPORT THERAPEUTICS, INC.
  • Organization Department
  • Organization DUNS
    159838106
  • Organization City
    IRVINE
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    926182343
  • Organization District
    UNITED STATES